Complete Filing Data
Avalo Therapeutics, Inc. reported Stockholders Equity of $83.05 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Avalo Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue * | $1.3M | $3.4M | $1.5M | $300.0K | -$566.5K | $3.3M | $635.6K | $0.00 | $0.00 | ||||
| Revenue * | $59.0K | $441.0K | $1.9M | $18.1M | $5.4M | $6.7M | $6.8M | $7.0M | $27.8M | $1.2M | $0.00 | ||
| Net Income Loss | -$78.3M | -$35.1M | -$31.5M | -$41.7M | -$84.4M | -$63.5M | -$16.1M | -$40.1M | $11.9M | -$16.5M | -$10.5M | -$16.1M | -$13.0M |
| Interest Income Expense Nonoperating Net | $4.4M | $3.3M | -$3.4M | -$4.2M | -$2.4M | $49.0K | $121.3K | $16.3K | -$24.0K | -$464.2K | -$793.2K | -$1.2M | $10.6K |
| General And Administrative Expense | $22.9M | $17.2M | $10.3M | $20.7M | $24.7M | $17.4M | $10.1M | $10.5M | $7.9M | $7.1M | $4.4M | $4.9M | $4.0M |
| Operating Income Loss | -$72.9M | -$68.5M | -$27.4M | -$37.4M | -$82.1M | -$72.8M | -$16.1M | -$35.4M | $13.9M | -$16.1M | -$11.0M | -$17.1M | -$12.9M |
| Nonoperating Income Expense | -$5.2M | $33.5M | -$4.2M | -$4.2M | -$2.4M | $5.7M | $147.0K | $54.9K | -$53.6K | -$391.6K | $519.8K | $1.1M | -$110.6K |
| Income Tax Expense Benefit | $165.0K | $114.0K | $14.0K | $28.0K | -$196.0K | -$2.8M | $280.3K | -$49.5K | $2.0M | $0.00 | $0.00 | ||
| Research And Development Expense Excluding Acquired In Process Cost | $50.1M | $24.4M | $13.8M | $31.3M | $59.8M | $32.2M | $11.8M | $5.8M | |||||
| Research And Development Expense | $5.8M | $4.4M | $10.1M | $6.6M | $12.2M | $8.9M | |||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$78.1M | -$35.0M | -$31.5M | -$41.6M | |||||||||
| Deferred Income Tax Liabilities Net | $434.0K | $270.0K | $155.0K | $141.0K | $113.0K | $90.0K | $86.0K | $69.2K | $7.1K | $0.00 | |||
| Other Nonoperating Income Expense | -$5.0K | -$42.0K | -$20.0K | -$20.0K | $409.0K | -$28.3K | $13.7K | $0.00 | |||||
| Amortization Of Intangible Assets | $0.00 | $38.0K | $4.5M | $403.5K | |||||||||
| Deferred Income Tax Expense Benefit | $165.0K | $114.0K | $14.0K | $28.0K | $16.7K | -$16.7K | -$832.6K | $0.00 | $0.00 | ||||
| Selling And Marketing Expense | $2.8M | $2.3M | $1.5M | $545.2K | $569.8K | $0.00 | $0.00 | ||||||
| Revenue From Grants | $624.6K | $1.2M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue * | $0.00 | -$714.0K | $343.0K | -$80.0K | $247.0K | $708.0K | $551.0K | $528.0K | $1.6M | $720.0K | $908.0K | $83.0K | $77.0K | $77.0K | $78.0K | $66.0K | $132.4K | -$1.5M | $752.5K | $3.1M | $1.4M | $863.6K | $636.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Revenue * | $0.00 | $249.0K | $0.00 | $0.00 | $236.0K | $643.0K | $475.0K | $14.9M | $1.0M | $1.2M | $1.4M | $3.4M | $473.0K | $1.1M | $1.3M | $2.8M | $2.2M | $1.4M | $2.6M | $4.1M | $4.8M | $4.5M | $1.9M | $25.0M | $157.8K | $384.2K | $321.5K | |||||||||||||
| Net Income Loss | -$30.6M | -$20.8M | -$13.1M | $23.0M | $98.5M | -$121.3M | -$5.2M | -$8.2M | -$10.0M | $3.2M | -$13.0M | -$22.1M | -$17.4M | -$17.1M | -$30.7M | -$13.5M | -$13.3M | -$21.1M | -$4.0M | -$6.2M | -$7.5M | -$24.6M | -$6.0M | -$3.9M | -$3.1M | $18.7M | -$1.8M | -$2.0M | -$1.6M | -$6.2M | -$3.5M | -$5.1M | -$3.6M | -$692.0K | -$2.9M | -$3.2M | -$2.5M | -$5.8M | -$4.1M | -$3.6M |
| Interest Income Expense Nonoperating Net | $1.1M | $1.1M | $1.1M | $964.0K | $1.0M | $100.0K | -$1.6M | -$996.0K | -$949.0K | -$898.0K | -$1.2M | -$1.2M | -$985.0K | -$239.0K | $17.0K | $0.00 | $9.0K | $10.0K | -$205.9K | $38.4K | $30.2K | -$234.9K | -$242.4K | -$100.4K | $31.0K | $29.4K | -$25.6K | -$57.7K | -$83.0K | -$104.0K | -$127.0K | -$151.0K | -$158.0K | -$197.0K | -$219.0K | -$219.0K | -$221.0K | -$190.0K | -$795.0K | $0.00 |
| General And Administrative Expense | $5.6M | $5.2M | $5.5M | $4.3M | $4.5M | $3.2M | $2.5M | $2.4M | $2.7M | $9.8M | $5.2M | $6.6M | $4.9M | $4.6M | $6.1M | $2.7M | $2.6M | $2.3M | $2.7M | $1.9M | $3.0M | $2.9M | $3.0M | $2.2M | $1.4M | $1.3M | $1.1M | $1.7M | $1.6M | $2.6M | $1.9M | $722.0K | $1.0M | $761.0K | $1.6M | $1.6M | $794.0K | $879.0K | ||
| Operating Income Loss | -$19.2M | -$19.3M | -$14.7M | -$12.9M | -$9.6M | -$32.8M | -$3.8M | -$7.2M | -$8.8M | $4.1M | -$11.8M | -$20.9M | -$16.5M | -$17.1M | -$30.6M | -$13.3M | -$11.8M | -$31.4M | -$2.9M | -$2.5M | -$5.0M | -$24.3M | -$5.8M | -$3.8M | $21.9M | -$1.8M | -$1.9M | -$6.0M | -$3.5M | -$4.9M | -$2.0M | -$2.9M | -$2.5M | -$6.0M | ||||||
| Nonoperating Income Expense | -$11.4M | -$1.4M | $1.5M | $35.9M | $108.0M | -$88.5M | -$1.5M | -$1.0M | -$1.2M | -$898.0K | -$1.2M | -$1.2M | -$1.0M | -$244.0K | $17.0K | $19.0K | -$1.5M | $7.1M | $52.7K | $57.3K | -$26.8K | -$237.8K | -$238.5K | -$105.0K | $29.5K | -$23.5K | -$61.5K | -$205.4K | -$36.1K | -$197.6K | $1.3M | -$21.4K | -$753.6K | $158.6K | ||||||
| Income Tax Expense Benefit | $11.0K | $16.0K | $8.0K | -$14.0K | $7.0K | $7.0K | $8.0K | $7.0K | $8.0K | $5.0K | $5.0K | $9.0K | $8.0K | -$199.0K | $11.0K | $3.0K | -$454.0K | -$2.2M | $121.6K | $53.4K | $130.7K | $52.4K | $16.4K | $23.3K | $3.2M | $0.00 | $0.00 | $0.00 | ||||||||||||
| Research And Development Expense Excluding Acquired In Process Cost | $13.6M | $14.1M | $9.1M | $9.5M | $4.6M | $2.1M | $1.2M | $4.7M | $6.0M | $7.0M | $8.5M | $9.6M | $10.6M | $12.6M | $25.2M | $8.9M | $5.9M | $4.8M | $1.7M | $3.7M | $3.4M | $1.0M | $1.1M | $964.6K | ||||||||||||||||
| Research And Development Expense | $3.4M | $1.1M | $1.6M | $2.0M | $965.0K | $493.6K | $953.1K | $773.0K | $4.6M | $2.5M | $2.3M | $1.8M | $1.2M | $1.9M | $1.7M | $2.3M | $4.4M | $2.9M | $2.8M | |||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$30.6M | -$20.7M | -$13.1M | $23.0M | $98.5M | -$121.3M | -$5.2M | -$8.2M | -$9.9M | $3.2M | -$13.0M | -$22.0M | -$17.5M | -$17.4M | -$30.6M | -$13.3M | -$13.3M | -$24.3M | -$2.8M | -$2.5M | -$5.0M | $22.0M | -$6.2M | |||||||||||||||||
| Deferred Income Tax Liabilities Net | $304.0K | $293.0K | $278.0K | $154.0K | $168.0K | $162.0K | $164.0K | $156.0K | $148.0K | $133.0K | $128.0K | $122.0K | $130.0K | $122.0K | $111.0K | $115.0K | $0.00 | $106.7K | $98.1K | $88.1K | $75.2K | $38.0K | $30.9K | $23.1K | ||||||||||||||||
| Other Nonoperating Income Expense | -$3.0K | -$5.0K | -$5.0K | $0.00 | $0.00 | -$17.0K | $0.00 | -$26.0K | $0.00 | $0.00 | -$20.0K | -$15.0K | -$5.0K | $0.00 | $19.0K | $398.0K | $11.0K | |||||||||||||||||||||||
| Amortization Of Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $38.0K | $428.0K | $428.0K | $424.0K | $404.0K | $404.0K | $431.0K | $334.7K | $334.7K | $334.7K | $1.1M | $1.2M | $1.0M | $0.00 | $0.00 | $0.00 | |||||||||||||||||||
| Deferred Income Tax Expense Benefit | $8.0K | $7.0K | $8.0K | $9.0K | $21.0K | $21.0K | $5.9K | $15.9K | $0.00 | |||||||||||||||||||||||||||||||
| Selling And Marketing Expense | $1.9M | $738.0K | $786.0K | $435.0K | $462.0K | $653.0K | $677.0K | $214.2K | $325.9K | $396.3K | $2.3M | $2.0M | $1.5M | $973.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||
| Revenue From Grants | $0.00 | $45.0K | $38.0K | $158.0K | $384.2K | $182.0K | $321.5K | $650.5K | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $83.0M | $133.0M | $7.3M | -$10.9M | $23.1M | $24.6M | $21.0M | $20.9M | $27.9M | $207.0K | $13.1M | -$26.3M | -$17.8M | -$11.4M |
| Cash And Cash Equivalents At Carrying Value | $15.9M | $134.5M | $7.4M | $13.2M | $54.6M | $18.9M | $3.6M | $10.6M | $2.5M | $5.1M | $21.2M | $11.7M | $3.4M | $9.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $16.1M | $134.7M | $7.5M | $13.3M | $54.9M | $19.1M | $3.7M | $10.7M | $2.6M | $5.2M | ||||
| Restricted Cash And Cash Equivalents At Carrying Value | $37.0K | $19.0K | $1.0K | $15.0K | $51.0K | $38.0K | $17.5K | $18.7K | $2.0K | $11.1K | $58.8K | $58.3K | ||
| Restricted Cash And Cash Equivalents Noncurrent | $210.0K | $131.0K | $131.0K | $131.0K | $227.0K | $149.0K | $101.9K | $81.7K | $131.4K | $62.8K | $0.00 | $117.2K | ||
| Retained Earnings Accumulated Deficit | -$448.5M | -$370.3M | -$335.1M | -$303.8M | -$262.2M | -$177.8M | -$114.3M | -$98.2M | -$58.2M | -$70.0M | -$53.6M | -$43.1M | ||
| Prepaid Expense And Other Assets Current | $6.9M | $4.3M | $843.0K | $1.3M | $2.4M | $2.7M | $707.0K | $732.0K | $703.2K | $391.3K | $401.6K | $360.3K | ||
| Liabilities Current | $12.9M | $7.0M | $4.6M | $22.1M | $19.9M | $15.2M | $12.2M | $26.2M | $11.1M | $4.3M | $5.8M | $5.0M | ||
| Liabilities And Stockholders Equity | $116.5M | $150.7M | $21.0M | $33.4M | $80.2M | $43.8M | $36.1M | $70.3M | $42.8M | $5.8M | $21.7M | $12.3M | ||
| Liabilities | $33.4M | $17.7M | $13.7M | $44.3M | $57.1M | $19.2M | $15.1M | $49.3M | $14.9M | $5.6M | $8.6M | $10.3M | ||
| Common Stock Value | $18.0K | $10.0K | $1.0K | $0.00 | $9.0K | $75.0K | $44.4K | $40.8K | $31.3K | $9.4K | $8.7K | $650.00 | ||
| Assets Current | $105.3M | $138.9M | $8.4M | $16.4M | $61.8M | $26.0M | $17.7M | $21.9M | $10.7M | $5.7M | $21.6M | $12.2M | ||
| Assets | $116.5M | $150.7M | $21.0M | $33.4M | $80.2M | $43.8M | $36.1M | $70.3M | $42.8M | $5.8M | $21.7M | $12.3M | ||
| Accrued Liabilities And Other Liabilities | $12.8M | $6.3M | $4.2M | $13.2M | $16.5M | $11.3M | $5.6M | $14.3M | $7.5M | $948.0K | $1.9M | $975.1K | ||
| Accounts Payable Current | $137.0K | $283.0K | $446.0K | $2.9M | $3.4M | $2.6M | $2.1M | $1.4M | $1.3M | $1.0M | $678.1K | $931.1K | ||
| Other Liabilities Noncurrent | $35.0K | $350.0K | $1.4M | $1.7M | $2.3M | $1.9M | $1.1M | $385.5K | $24.3K | $0.00 | $370.5K | |||
| Goodwill | $10.5M | $10.5M | $10.5M | $14.4M | $14.4M | $14.4M | $14.4M | $14.4M | $12.3M | $0.00 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$118.6M | $127.1M | -$5.8M | -$41.5M | $35.8M | $15.4M | -$7.0M | $8.1M | -$2.6M | |||||
| Inventory Net | $0.00 | $20.0K | $38.0K | $3.0K | $21.3K | $317.9K | $382.2K | $0.00 | ||||||
| Accrued Royalties Current And Noncurrent | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $0.00 | |||||||
| Repayments Of Long Term Debt | $0.00 | $256.1K | $0.00 | $2.4M | $3.3M | $1.8M | $0.00 | |||||||
| Property Plant And Equipment Net | $586.5K | $44.6K | $43.2K | $35.2K | $38.7K | |||||||||
| Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization | $460.0K | $1.2M | $2.0M | $2.4M | $2.7M | $1.6M | $1.4M | |||||||
| Preferred Stock Value | $0.00 | $1.0K | $2.9K | $2.9K | $0.00 | $0.00 | $0.00 | |||||||
| Other Receivables Net Current | $611.0K | $136.0K | $1.9M | $3.7M | $2.2M | $4.2M | $5.3M | |||||||
| Intangible Assets Net Excluding Goodwill | $0.00 | $38.0K | $1.6M | $2.4M | $3.8M | $17.7M | $0.00 | |||||||
| Accounts Receivable Net | $0.00 | $1.1M | $2.2M | $1.0M | $822.3K | $2.9M | $132.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $91.5M | $104.6M | $122.6M | $21.1M | -$13.6M | -$112.5M | $14.7M | -$7.0M | -$6.3M | -$2.0M | -$6.0M | $6.3M | $40.3M | $21.6M | $33.2M | $38.6M | $50.6M | $25.6M | $18.2M | $17.7M | $23.1M | $19.5M | $19.2M | $24.6M | $22.1M | $3.1M | -$425.8K | $586.8K | $5.6M | $8.9M | -$32.9M | ||||
| Cash And Cash Equivalents At Carrying Value | $27.0M | $42.3M | $125.0M | $81.9M | $93.4M | $110.2M | $10.2M | $6.3M | $16.7M | $16.9M | $11.2M | $38.5M | $71.5M | $40.4M | $38.3M | $33.4M | $45.4M | $5.7M | $5.3M | $9.4M | $16.1M | $6.8M | $2.2M | $2.5M | $24.0M | $5.5M | $3.0M | $8.8M | $11.9M | $16.6M | $3.3M | $6.1M | $8.7M | $15.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $27.3M | $42.5M | $125.2M | $82.0M | $93.6M | $110.3M | $10.3M | $6.5M | $16.9M | $17.2M | $11.5M | $38.8M | $71.9M | $40.6M | $38.6M | $33.7M | $45.6M | $5.8M | $5.5M | $9.6M | $16.3M | $7.1M | $2.4M | $2.7M | $24.0M | $5.5M | $3.1M | ||||||||
| Restricted Cash And Cash Equivalents At Carrying Value | $90.0K | $20.0K | $62.0K | $41.0K | $0.00 | $4.0K | $1.0K | $15.0K | $63.0K | $53.0K | $14.0K | $100.0K | $164.0K | $41.0K | $153.0K | $132.0K | $33.0K | $65.0K | $102.2K | $26.3K | $77.8K | $37.0K | $9.5K | $14.0K | $29.2K | $13.3K | $20.2K | $87.9K | $58.8K | $58.8K | |||||
| Restricted Cash And Cash Equivalents Noncurrent | $210.0K | $210.0K | $131.0K | $131.0K | $131.0K | $131.0K | $131.0K | $131.0K | $131.0K | $181.0K | $227.0K | $227.0K | $227.0K | $149.0K | $149.0K | $149.0K | $180.0K | $113.0K | $101.9K | $152.2K | $77.1K | $179.7K | $175.0K | $131.4K | $62.8K | $62.8K | $62.8K | $50.0K | $117.2K | ||||||
| Retained Earnings Accumulated Deficit | -$434.8M | -$404.2M | -$383.4M | -$334.9M | -$358.0M | -$456.4M | -$327.0M | -$321.7M | -$313.8M | -$294.0M | -$297.2M | -$284.2M | -$243.0M | -$225.6M | -$208.5M | -$162.1M | -$148.7M | -$135.4M | -$115.9M | -$111.9M | -$105.7M | -$92.7M | -$68.1M | -$62.0M | -$55.1M | -$73.8M | -$72.0M | -$68.4M | -$62.2M | -$58.7M | -$49.9M | ||||
| Prepaid Expense And Other Assets Current | $2.1M | $1.9M | $1.8M | $3.3M | $2.4M | $997.0K | $940.0K | $1.1M | $1.6M | $1.1M | $1.9M | $2.7M | $1.4M | $1.8M | $2.5M | $1.5M | $823.9K | $777.4K | $1.7M | $865.1K | $1.2M | $1.3M | $954.5K | $774.3K | $341.0K | $402.3K | $249.6K | $210.0K | $542.0K | $231.5K | $105.1K | ||||
| Liabilities Current | $8.0M | $9.3M | $5.6M | $60.7M | $96.4M | $215.7M | $6.0M | $22.5M | $23.2M | $18.1M | $15.4M | $17.9M | $19.0M | $21.7M | $26.4M | $16.6M | $14.6M | $15.3M | $17.3M | $18.8M | $28.1M | $24.9M | $19.0M | $14.8M | $4.8M | $1.7M | $2.7M | $7.5M | $6.6M | $6.2M | $6.7M | ||||
| Liabilities And Stockholders Equity | $125.1M | $126.6M | $138.5M | $98.5M | $108.3M | $123.7M | $29.3M | $24.2M | $36.2M | $36.5M | $32.2M | $61.9M | $95.4M | $64.1M | $63.3M | $59.2M | $69.2M | $44.1M | $57.2M | $59.6M | $74.9M | $67.6M | $62.1M | $65.4M | $28.2M | $6.0M | $3.6M | $9.6M | $13.2M | $16.9M | $5.5M | ||||
| Liabilities | $33.6M | $22.0M | $15.9M | $75.7M | $110.5M | $224.8M | $14.6M | $31.2M | $42.5M | $38.6M | $38.2M | $55.6M | $55.0M | $42.5M | $30.2M | $20.6M | $18.6M | $18.5M | $39.0M | $41.9M | $51.7M | $48.1M | $42.9M | $40.8M | $6.1M | $2.9M | $4.0M | $9.0M | $7.6M | $8.0M | $10.0M | ||||
| Common Stock Value | $18.0K | $11.0K | $11.0K | $10.0K | $1.0K | $1.0K | $192.0K | $14.0K | $13.0K | $9.0K | $9.0K | $113.0K | $112.0K | $96.0K | $89.0K | $74.9K | $74.9K | $59.6K | $44.1K | $42.9K | $42.8K | $40.7K | $33.8K | $31.4K | $26.1K | $14.1K | $10.9K | $9.1K | $8.7K | $8.7K | $650.00 | ||||
| Assets Current | $113.8M | $115.2M | $126.9M | $86.1M | $95.9M | $111.2M | $12.7M | $7.5M | $19.3M | $19.5M | $15.0M | $43.7M | $77.0M | $47.4M | $46.1M | $41.0M | $50.2M | $25.5M | $12.6M | $13.9M | $26.7M | $18.5M | $11.8M | $13.4M | $28.1M | $6.0M | $3.5M | $9.5M | $13.1M | $16.9M | $3.4M | ||||
| Assets | $125.1M | $126.6M | $138.5M | $98.5M | $108.3M | $123.7M | $29.3M | $24.2M | $36.2M | $36.5M | $32.2M | $61.9M | $95.4M | $64.1M | $63.3M | $59.2M | $69.2M | $44.1M | $57.2M | $59.6M | $74.9M | $67.6M | $62.1M | $65.4M | $28.2M | $6.0M | $3.6M | $9.6M | $13.2M | $16.9M | $5.5M | ||||
| Accrued Liabilities And Other Liabilities | $7.5M | $6.5M | $4.6M | $7.0M | $7.9M | $7.4M | $5.2M | $7.6M | $8.3M | $13.7M | $13.2M | $14.1M | $15.5M | $17.6M | $14.2M | $8.8M | $6.5M | $6.2M | $13.1M | $13.3M | $21.8M | $18.2M | $10.3M | $7.7M | $1.3M | $720.1K | $639.0K | $3.4M | $2.4M | $2.2M | $1.5M | ||||
| Accounts Payable Current | $474.0K | $2.4M | $681.0K | $1.8M | $654.0K | $916.0K | $789.0K | $751.0K | $5.6M | $1.4M | $2.2M | $3.8M | $3.6M | $4.0M | $11.9M | $1.9M | $2.6M | $2.7M | $826.5K | $1.4M | $1.2M | $1.5M | $2.9M | $3.2M | $312.5K | $327.3K | $595.9K | $809.2K | $756.5K | $591.0K | $2.0M | ||||
| Other Liabilities Noncurrent | $117.0K | $197.0K | $275.0K | $1.1M | $1.2M | $1.3M | $1.5M | $1.5M | $1.6M | $1.8M | $1.9M | $2.4M | $1.4M | $1.6M | $1.7M | $1.9M | $2.0M | $1.1M | $1.1M | $1.2M | $1.2M | $0.00 | $0.00 | $304.2K | $1.5M | $404.1K | $388.6K | $107.2K | |||||||
| Goodwill | $10.5M | $10.5M | $10.5M | $10.5M | $10.5M | $10.5M | $14.4M | $14.4M | $14.4M | $14.4M | $14.4M | $14.4M | $14.4M | $14.4M | $14.4M | $14.4M | $14.4M | $14.4M | $16.4M | $16.4M | $16.4M | $16.4M | $18.1M | $18.7M | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$9.5M | $102.8M | $3.6M | -$16.1M | $19.5M | $2.1M | $5.5M | $63.7K | |||||||||||||||||||||||||||
| Inventory Net | $0.00 | $18.0K | $19.0K | $22.0K | $23.0K | $25.0K | $16.0K | $20.0K | $0.00 | $9.1K | $12.2K | $16.3K | $402.3K | $617.6K | $1.0M | $1.1M | $1.5M | $3.4M | |||||||||||||||||
| Accrued Royalties Current And Noncurrent | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | |||||||||||||||||
| Repayments Of Long Term Debt | $0.00 | $24.3K | $0.00 | $874.7K | $803.9K | ||||||||||||||||||||||||||||||
| Property Plant And Equipment Net | $1.7M | $1.7M | $1.4M | $1.4M | $1.5M | $1.5M | $1.5M | $92.1K | $58.4K | $58.2K | $34.2K | $33.4K | $39.2K | $40.4K | $41.0K | $37.3K | $41.4K | ||||||||||||||||||
| Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization | $542.0K | $686.0K | $949.0K | $1.7M | $1.8M | $1.9M | $2.1M | $2.2M | $2.4M | $2.5M | $2.6M | $2.6M | $1.4M | $1.4M | $1.5M | ||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $1.0K | $1.3K | $1.3K | $1.3K | $2.9K | $2.9K | $2.9K | $0.00 | $0.00 | $0.00 | $0.00 | $4.00 | |||||||||||||||||||||
| Other Receivables Net Current | $998.0K | $33.0K | $35.0K | $1.5M | $6.0K | $857.0K | $1.3M | $1.3M | $1.4M | $2.5M | $998.0K | $2.1M | $4.3M | $2.0M | $2.1M | ||||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $0.00 | $0.00 | $0.00 | $304.0K | $732.0K | $1.2M | $1.9M | $2.3M | $2.7M | $26.6M | $27.6M | $30.2M | $32.5M | $32.0M | $33.1M | ||||||||||||||||||||
| Accounts Receivable Net | $0.00 | $544.0K | $938.0K | $1.4M | $4.1M | $3.1M | $1.7M | $2.0M | $2.2M | $5.0M | $2.9M | $2.7M | $3.0M | $3.3M | $2.8M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $14.6M | $175.8M | $25.0M | -$14.7M | $106.8M | $44.8M | $12.6M | $10.4M | $3.7M | -$1.4M | $19.6M | $23.9M | $5.4M |
| Investing Cash Flow * | -$81.7M | $356.0K | -$133.0K | -$95.0K | -$113.0K | $11.1M | -$443.0K | $865.5K | -$18.9M | -$34.9K | -$20.0K | -$19.5K | -$29.3K |
| Operating Cash Flow * | -$51.5M | -$49.1M | -$30.7M | -$26.8M | -$70.9M | -$40.5M | -$19.1M | -$3.1M | $12.6M | -$14.6M | -$10.2M | -$15.5M | -$11.5M |
| Share Based Compensation | $13.6M | $5.9M | $3.5M | $7.6M | $8.2M | $6.8M | $2.5M | $2.4M | $1.2M | $1.7M | $394.7K | $1.1M | $748.6K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.6M | $2.9M | -$447.0K | -$1.1M | -$287.0K | $1.9M | $917.0K | $241.6K | $177.7K | -$22.0K | $41.2K | -$354.0K | -$271.0K |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $6.7M | -$1.1M | -$9.0M | -$3.6M | $3.3M | -$196.0K | -$6.8M | $7.8M | $2.0M | -$119.5K | $1.1M | -$28.4K | $271.9K |
| Increase Decrease In Accounts Payable | -$146.0K | -$163.0K | -$2.4M | -$487.0K | $796.0K | $99.0K | $1.0M | $82.5K | $96.1K | $332.1K | -$268.7K | -$708.4K | $818.4K |
| Depreciation Depletion And Amortization | $344.0K | $169.0K | $158.0K | $166.0K | $1.7M | $1.8M | $3.9M | $4.6M | $425.5K | $26.9K | $23.5K | ||
| Payments To Acquire Property Plant And Equipment | $95.0K | $113.0K | $63.0K | $262.0K | $564.4K | $23.3K | $34.9K | $20.0K | $19.5K | $29.3K | |||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $7.6M | $8.2M | $6.8M | $2.5M | $2.4M | $1.2M | $1.7M | $394.7K | $1.1M | $748.6K | |||
| Proceeds From Stock Plans | $23.0K | $68.0K | $67.0K | $73.0K | $366.0K | $312.0K | $210.8K | $72.2K | $46.9K | $0.00 | $0.00 | ||
| Increase Decrease In Other Receivables | $0.00 | $475.0K | -$1.8M | -$1.8M | $1.5M | $2.1M | -$5.1M | $2.3M | $427.2K | $0.00 | $0.00 | ||
| Increase Decrease In Inventories | $0.00 | -$20.0K | -$18.0K | $35.0K | -$18.0K | -$532.9K | $311.2K | $24.3K | $0.00 | $0.00 | |||
| Proceeds From Issuance Of Private Placement | $0.00 | $115.6M | $0.00 | $0.00 | $3.9M | $3.7M | $3.9M | $4.6M | $0.00 | $0.00 | |||
| Proceeds From Issuance Of Common Stock | $14.8M | $0.00 | $32.5M | $0.00 | $29.0M | $35.4M | $9.0M | $0.00 | $1.7M | $2.0M | $0.00 | $0.00 | |
| Increase Decrease In Accounts Receivable | $0.00 | -$1.1M | -$1.1M | $678.0K | -$1.7M | $222.5K | $247.2K | $132.5K | $0.00 | ||||
| Increase Decrease In Lease Liability | -$87.0K | -$88.0K | -$76.0K | -$9.0K | -$45.0K | -$2.0K | $125.5K | ||||||
| Increase Decrease In Accrued Income Taxes Payable | $0.00 | $0.00 | $288.0K | -$1.5M | -$226.9K | $2.3M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q2 2017 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $0.00 | $108.6M | $13.7M | $0.00 | $37.8M | $9.1M | $8.8M | $363.4K | $121.0K | -$844.9K | -$15.8K | ||||||||||||
| Investing Cash Flow * | $0.00 | $356.0K | -$133.0K | $0.00 | -$21.0K | -$1.3M | -$166.0K | -$19.2K | -$1.8K | -$8.9K | |||||||||||||
| Operating Cash Flow * | -$9.5M | -$6.2M | -$10.1M | -$16.1M | -$18.3M | -$5.7M | -$3.1M | -$280.4K | -$2.2M | -$3.7M | -$3.1M | ||||||||||||
| Share Based Compensation | $3.2M | $629.0K | $855.0K | $5.3M | $1.4M | $1.1M | $596.7K | $242.8K | $332.2K | $937.3K | $50.2K | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.5M | $53.0K | $337.0K | $310.0K | -$195.0K | -$23.0K | -$281.1K | $71.1K | -$141.7K | -$170.0K | $14.1K | ||||||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$1.7M | -$1.7M | -$4.9M | -$2.3M | $1.7M | -$142.0K | $2.1M | $160.6K | -$303.5K | $291.5K | -$355.3K | ||||||||||||
| Increase Decrease In Accounts Payable | $398.0K | $470.0K | $2.7M | $388.0K | $9.3M | $251.0K | -$196.7K | $1.9M | -$414.3K | -$71.4K | -$209.1K | ||||||||||||
| Depreciation Depletion And Amortization | $135.0K | $34.0K | $33.0K | $67.0K | $451.0K | $453.0K | $1.1M | $1.0M | $5.8K | ||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $21.0K | $0.00 | $166.0K | $19.2K | $1.8K | $8.9K | ||||||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $893.0K | $855.0K | $731.0K | $669.0K | $5.3M | $1.8M | $3.1M | $1.4M | $1.4M | $2.8M | $1.1M | $818.8K | $526.7K | $596.7K | $945.1K | $608.4K | $242.8K | ||||||
| Proceeds From Stock Plans | $94.2K | $363.4K | $0.00 | ||||||||||||||||||||
| Increase Decrease In Other Receivables | -$101.0K | -$1.1M | -$2.3M | -$152.0K | $2.0M | $62.0K | -$371.7K | $0.00 | |||||||||||||||
| Increase Decrease In Inventories | $0.00 | -$1.0K | -$13.0K | -$3.0K | -$5.0K | -$41.2K | $554.4K | $0.00 | |||||||||||||||
| Proceeds From Issuance Of Private Placement | $0.00 | $115.6M | $0.00 | $0.00 | $3.9M | $0.00 | $5.0M | ||||||||||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $9.0M | $0.00 | $1.2M | $0.00 | ||||||||||||||||||
| Increase Decrease In Accounts Receivable | $0.00 | -$123.0K | $953.0K | $696.0K | -$439.2K | -$104.7K | $0.00 | ||||||||||||||||
| Increase Decrease In Lease Liability | $7.0K | -$186.0K | -$13.0K | $25.0K | -$16.0K | $158.0K | $0.00 | ||||||||||||||||
| Increase Decrease In Accrued Income Taxes Payable | $0.00 | -$551.0K | -$217.6K | $7.4K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$5.84 | -$20.91 | -$113.58 | -$1.1K | -$1.20 | $0.42 | -$1.87 | -$4.71 | -$5.48 | -$20.72 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 18.5M | 10.5M | 801.7K | 39.3K | 9.4M | 75.0M | 44.4M | 40.8M | 31.3M | 9.4M | 8.7M | 649.7K | |
| Common Stock Shares Issued | 18.5M | 10.5M | 801.7K | 39.3K | 9.4M | 75.0M | 44.4M | 40.8M | 31.3M | 9.4M | 8.7M | 649.7K | |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 230.0M | |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 0.00 | 5.0M | 0.00 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 1.3M | 2.9M | 2.9M | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 1.3M | 2.9M | 2.9M | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Earnings Per Share Basic | $-5.84 | $-7.94 | $-113.58 | $-1,063.00 | $-1.20 | $0.42 | $-1.87 | $-4.71 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.19 | -$1.92 | -$1.25 | -$2.83 | -$14.07 | -$141.14 | -$26.83 | -$140.73 | -$204.00 | $0.34 | -$1.38 | -$2.35 | -$0.71 | -$0.19 | -$0.12 | -$0.11 | $0.52 | -$0.14 | -$0.19 | -$0.18 | -$0.70 | -$0.41 | -$0.59 | -$0.53 | -$1.06 | -$4.48 | -$4.98 | -$3.88 | $10.35 | -$6.39 | -$5.71 | |||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Common Stock Shares Outstanding | 17.8M | 10.8M | 10.8M | 9.7M | 1.0M | 1.0M | 192.4M | 14.0M | 13.2M | 9.4M | 9.4M | 112.8M | 112.3M | 96.0M | 89.1M | 74.9M | 74.9M | 59.6M | 44.1M | 42.9M | 42.8M | 40.7M | 33.8M | 31.4M | 26.1M | 14.1M | 10.9M | 9.1M | 8.7M | 8.7M | 649.7K | |||||||||
| Common Stock Shares Issued | 17.8M | 10.8M | 10.8M | 9.7M | 1.0M | 1.0M | 192.4M | 14.0M | 13.2M | 9.4M | 9.4M | 112.8M | 112.3M | 96.0M | 89.1M | 74.9M | 74.9M | 59.6M | 44.1M | 42.9M | 42.8M | 40.7M | 33.8M | 31.4M | 26.1M | 14.1M | 10.9M | 9.1M | 8.7M | 8.7M | 649.7K | |||||||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 8.2M | |||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||||||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 1.3M | 1.3M | 1.3M | 1.3M | 2.9M | 2.9M | 2.9M | 0.00 | 0.00 | 0.00 | 0.00 | 4.2K | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 1.3M | 1.3M | 1.3M | 1.3M | 2.9M | 2.9M | 2.9M | 0.00 | 0.00 | 0.00 | 0.00 | 4.2K | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||
| Earnings Per Share Basic | $-2.19 | $-1.92 | $-1.25 | $0.98 | $4.21 | $-141.14 | $-26.83 | $-140.73 | $-204.00 | $0.34 | $-1.38 | $-2.35 | $-0.11 | $0.52 | $-0.14 | $-0.19 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $531.5M | $503.3M | $342.4M | $292.9M | $285.2M | $202.3M | $135.2M | $119.1M | $83.3M | $70.2M | $66.6M | $16.7M | |
| Fair Value Adjustment Of Warrants And Investor Rights Obligation | $0.00 | -$14.0K | $3.9K | -$25.0K | $29.6K | -$72.6K | -$1.3M | -$2.3M | $121.1K | ||||
| Costs And Expenses | $73.0M | $69.0M | $29.3M | $55.5M | $87.5M | $79.5M | $22.9M | $42.4M | |||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $23.0K | $68.0K | $67.0K | $73.0K | $366.0K | $312.0K | $210.8K | $72.2K | $46.9K | $0.00 | |||
| Interest Paid Net | $0.00 | $1.9M | $2.9M | $1.6M | $0.00 | $1.1M | $525.0K | $72.5K | |||||
| Stock Issued During Period Value New Issues | $14.3M | $32.5M | $35.4M | $9.0M | $0.00 | $1.5M | $1.9M | $21.2M | |||||
| Paid In Kind Interest | $0.00 | $302.9K | $20.4K | $162.3K | $293.7K | $989.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $526.3M | $508.8M | $506.0M | $356.0M | $344.4M | $343.9M | $341.5M | $314.8M | $307.5M | $292.0M | $291.2M | $290.4M | $283.2M | $247.1M | $241.5M | $200.6M | $199.2M | $160.9M | $134.1M | $129.5M | $128.7M | $112.1M | $87.2M | $83.9M | $77.2M | $76.9M | $71.6M | $69.0M | $67.8M | $67.6M | $17.1M | ||||||||
| Fair Value Adjustment Of Warrants And Investor Rights Obligation | $0.00 | -$11.0K | $47.6K | $23.3K | $28.0K | $0.00 | -$2.0K | $3.8K | -$130.0K | $101.0K | -$91.0K | $47.0K | -$185.0K | -$1.5M | -$198.0K | $535.0K | -$1.5M | -$348.0K | -$386.0K | ||||||||||||||||||||
| Costs And Expenses | $19.2M | $19.3M | $14.7M | $13.1M | $9.6M | $32.8M | $4.0M | $7.8M | $9.3M | $10.9M | $12.9M | $22.0M | $17.8M | $20.5M | $31.1M | $14.4M | $13.2M | $34.2M | $5.1M | $3.9M | $7.6M | ||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $40.0K | $67.0K | $25.0K | $207.0K | $133.0K | $127.5K | $8.4K | ||||||||||||||||||||||||||||||||
| Interest Paid Net | $0.00 | $704.0K | $831.0K | $0.00 | $0.00 | $262.5K | $44.0K | ||||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $14.4M | $25.9M | $6.5M | $13.7M | $37.7M | $35.4M | $9.0M | $0.00 | |||||||||||||||||||||||||||||||
| Paid In Kind Interest | $0.00 | $105.5K | $13.4K | $52.1K | $69.4K |
Most recent annual filing with the SEC: March 23, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.